EPOFIT 3000 IU INJECTION

Epofit 3000cIU injection has active components like Recombinant Human Erythropoietin Alpha/Epoe. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication helps treat anaemia due to chronic kidney diseases (CKD), as well as cancer chemotherapy or HIV treatment using zidovudine. It also reduces the requirement for transfusions of red blood cells for patients at risk of losing blood due to surgery planned and other therapies.
Epofit 3000cIU injections should not be administered to patients suffering from uncontrolled hypertension or hypersensitivity active thrombotic microangiopathy (TMA), Pure red cell cancer (PRCA), uncontrolled seizures, and pregnancy or lactation. It is also recommended to use it carefully in patients who have a background of bleeding clots or heart disease, kidney disease, stroke thalassemia, liver disorder, sickle cell anaemia and myelodysplastic disorder, leukaemia or cancer. It should not be used in children under 18 in cases where the benefits are more significant than the risks. Older adults taking this medication should be monitored closely for any adverse effects. Before you begin this treatment, you must speak with your physician regarding the potential risks and benefits associated with Epofit 3000IU injectionv.